<span id="b0blp"></span>

Sage Therapeutics Stock Is Dropping. A Workforce Reduction Is Hitting R&D Hard.

Sage Therapeutics Stock Is Dropping. A Workforce Reduction Is Hitting R&D Hard. · Barrons.com

Emily Dattilo

Thu, Oct 17, 2024, 6:47 AM 1 min read

In This Article:

The biopharmaceutical company says the reorganization is meant to strengthen its balance sheet and position it for long-term growth.

and

WA Consumer Health Privacy Policy

Your privacy controls

<li id="ffsxg"><dl id="ffsxg"><sup id="ffsxg"></sup></dl></li>

<rt id="ffsxg"></rt>

<li id="ffsxg"><dl id="ffsxg"><sup id="ffsxg"></sup></dl></li><li id="ffsxg"><dl id="ffsxg"><ruby id="ffsxg"></ruby></dl></li>